FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

Data Compilation
#PharmaFlow

Stock Recap
#PipelineProspector

Riboflavin Phosphate Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

21 API Suppliers, 7 USDMF, 3 CEP/COS, 4 JDMF, 2 EU WC, 11 NDC API, 7 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

40 FDF Dossiers, 14 FDA Orange Book, 21 Europe, 2 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 14 SPI Pharma, 1 Pharm-RX Chemical, 3 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 5 Kirsch Pharma, 4 ACG Worldwide, 6 Actylis, 4 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 2 Finar, 6 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 1 Kerry, 3 Lonza Capsugel, 2 Microlex e.U, 1 Nanjing Bold Chemical, 3 Pluviaendo, 1 Qualicaps, 14 Roquette, 8 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

25 Parenteral, 21 Fillers, Diluents & Binders, 18 Solubilizers, 17 Taste Masking, 14 Film Formers & Plasticizers, 13 Chewable & Orodispersible Aids, 12 Topical, 11 Direct Compression, 8 Empty Capsules, 7 Thickeners and Stabilizers, 7 Disintegrants & Superdisintegrants, 6 Surfactant & Foaming Agents, 5 Emulsifying Agents, 5 Coating Systems & Additives, 4 Co-Processed Excipients, 3 Granulation, 1 Rheology Modifiers, 1 Soft Gelatin, 1 API Stability Enhancers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 4 News #PharmaBuzz

MARKET PLACE

17 APIs, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

1 US Exclusivities

1 US Exclusivities

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Labeler	NDC Package Code	Non Proprietary Name	Start Marketing Date	End Marketing Date	Category Code	Dosage Form (Strength)
29/01/2026	Supriya Lifescience	India	Supriya Lifescience Limited	61281-7000	Riboflavin 5 Phosphate Sodium	2013-11-21	2026-12-31	BULK INGREDIENT	POWDER (1kg/kg)
04/02/2026	Willow Birch Pharma	U.S.A	Willow Birch Pharma, LLC	10695-330	Riboflavin 5-Phosphate Sodium	2026-01-08	2027-12-31	BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING	POWDER (1kg/kg)

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Riboflavin Phosphate Sodium

Riboflavin Phosphate Sodium

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

21 API Suppliers

7 USDMF

3 CEP/COS

4 JDMF

2 EU WC

11 NDC API

7 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

40 FDF Dossiers

14 FDA Orange Book

21 Europe

2 South Africa

3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML

INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL

INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

3 Rochem International Inc

14 SPI Pharma

1 Pharm-RX Chemical

3 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Pfanstiehl

5 Kirsch Pharma

4 ACG Worldwide

6 Actylis

4 BASF

1 Bioplus Life Sciences

1 CD Formulation

2 Finar

6 Gangwal Chemicals

1 Ingredion Pharma Solutions

1 Kerry

3 Lonza Capsugel

2 Microlex e.U

1 Nanjing Bold Chemical

3 Pluviaendo

1 Qualicaps

14 Roquette

8 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

25 Parenteral

21 Fillers, Diluents & Binders

18 Solubilizers

17 Taste Masking

14 Film Formers & Plasticizers

13 Chewable & Orodispersible Aids

12 Topical

11 Direct Compression

8 Empty Capsules

7 Thickeners and Stabilizers

7 Disintegrants & Superdisintegrants

6 Surfactant & Foaming Agents

5 Emulsifying Agents

5 Coating Systems & Additives

4 Co-Processed Excipients

3 Granulation

1 Rheology Modifiers

1 Soft Gelatin

1 API Stability Enhancers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow